Erbitux 100mg Infusion
Prescription Required
Product introduction
Erbitux 100mg Infusion is used in the treatment of head and neck cancer and cancer of colon and rectum. It helps to mark the cancer cells for destruction by the body's immune system.
Erbitux 100mg Infusion is used to treat different types of cancer of intestines, head and neck
Erbitux 100mg Infusion is used to treat different types of cancer of intestines, head and neck
Uses of Erbitux Infusion
Benefits of Erbitux Infusion
In Head and neck cancer
Head and neck cancer includes cancer of the mouth, nose, sinuses or throat. Erbitux 100mg Infusion kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.
In Cancer of colon and rectum
Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Erbitux 100mg Infusion treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine, but has some bothersome side effects. Consult your doctor if you have any concerns.
Side effects of Erbitux Infusion
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Erbitux
- Nausea
- Headache
- Vomiting
- Conjunctivitis
- Skin rash
- Diarrhea
- Infusion reaction
- Decreased magnesium level in blood
- Increased liver enzymes
How to use Erbitux Infusion
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Erbitux 100mg Infusion. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Erbitux 100mg Infusion may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Erbitux 100mg Infusion is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Erbitux 100mg Infusion may cause side effects which could affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Erbitux 100mg Infusion is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Erbitux 100mg Infusion may not be needed in these patients. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Erbitux 100mg Infusion in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Erbitux 100mg Infusion is given as an injection into the veins under the supervision of a doctor.
Fact Box
Chemical Class
Monoclonal antibody (mAb)
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
EGFR (ErbB1 or HER1) inhibitors- Monoclonal antibody
Patient concerns
User feedback
What are you using Erbitux Infusion for?
Cancer of col*
100%
*Cancer of colon and rectum
How much was the improvement?
Excellent
67%
Average
33%
What were the side-effects while using Erbitux 100mg Infusion?
Skin rash
100%
How do you take Erbitux Infusion?
With or witho*
100%
*With or without food
Please rate Erbitux 100mg Infusion on price
Expensive
100%
FAQs
Is Erbitux 100mg Infusion a chemotherapy drug?
Yes, Erbitux 100mg Infusion is a cytotoxic drug that is used in the chemotherapy of cancers of colon and rectum, and head-neck cancers.
Is Erbitux 100mg Infusion cytotoxic agent or vesicant or radiosensitizer?
It is not a radiosensitizer, but usually used in combination with radiotherapy to treat the cancers. It is not a vesicant (irritant).
How is Erbitux 100mg Infusion administered?
Erbitux 100mg Infusion is generally administered by intravenous (IV infusion) route, with or without radiotherapy.
Does Erbitux 100mg Infusion cause hair loss?
Yes. Erbitux 100mg Infusion is a chemotherapy agent, which may cause hair loss. Please consult your doctor if you experience such side effect.
Why does Erbitux 100mg Infusion cause a rash?
Erbitux 100mg Infusion may cause a rash. Consult your doctor if it bothers you.
How long does the rash last?
The duration of skin rash depends upon its type and severity. Please consult your doctor for advice..
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1736-37.
- Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 953-54.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 239-40.
- Cetuximab. Feltham, Middlesex: Merck; 2004 [revised Oct. 2018]. [Accessed 26 Mar. 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Cetuximab. [Updated 2018 Dec 3]. [Accessed 18 Feb. 2020] (online) Available from:
Marketer details
Name: Merck Ltd
Address: L-2, J.R. Complex, Gate No. 4, Village Mandoli, Delhi-110 093, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹94544.4
Inclusive of all taxes
50.0 ml in 1 bottle
SOLD OUT
Variants (2)
Notify me